Annual Total Long Term Liabilities
$52.30 M
+$44.18 M+543.75%
31 December 2023
Summary:
Crinetics Pharmaceuticals annual total long term liabilities is currently $52.30 million, with the most recent change of +$44.18 million (+543.75%) on 31 December 2023. During the last 3 years, it has risen by +$48.27 million (+1195.64%). CRNX annual total long term liabilities is now at all-time high.CRNX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$50.83 M
+$437.00 K+0.87%
30 September 2024
Summary:
Crinetics Pharmaceuticals quarterly total long term liabilities is currently $50.83 million, with the most recent change of +$437.00 thousand (+0.87%) on 30 September 2024. Over the past year, it has dropped by -$2.49 million (-4.68%). CRNX quarterly long term liabilities is now -46.06% below its all-time high of $94.24 million, reached on 30 June 2018.CRNX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRNX Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +543.8% | -4.7% |
3 y3 years | +1195.6% | +1427.0% |
5 y5 years | +1502.0% | +895.9% |
CRNX Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +1600.4% | -4.7% | +1552.5% |
5 y | 5 years | at high | +1600.4% | -4.7% | +1552.5% |
alltime | all time | at high | +1600.4% | -46.1% | +1552.5% |
Crinetics Pharmaceuticals Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $50.83 M(+0.9%) |
June 2024 | - | $50.40 M(-2.1%) |
Mar 2024 | - | $51.45 M(-1.6%) |
Dec 2023 | $52.30 M(+543.8%) | $52.30 M(-1.9%) |
Sept 2023 | - | $53.33 M(+716.9%) |
June 2023 | - | $6.53 M(-11.3%) |
Mar 2023 | - | $7.36 M(-9.4%) |
Dec 2022 | $8.13 M(+164.1%) | $8.13 M(-9.2%) |
Sept 2022 | - | $8.95 M(-5.3%) |
June 2022 | - | $9.45 M(-5.3%) |
Mar 2022 | - | $9.98 M(+224.6%) |
Dec 2021 | $3.08 M | $3.08 M(-7.6%) |
Sept 2021 | - | $3.33 M(-6.8%) |
June 2021 | - | $3.57 M(-6.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $3.81 M(-5.7%) |
Dec 2020 | $4.04 M(-17.6%) | $4.04 M(-5.3%) |
Sept 2020 | - | $4.26 M(-4.8%) |
June 2020 | - | $4.48 M(-4.5%) |
Mar 2020 | - | $4.69 M(-4.3%) |
Dec 2019 | $4.90 M(+50.0%) | $4.90 M(-4.0%) |
Sept 2019 | - | $5.10 M(-3.7%) |
June 2019 | - | $5.30 M(-4.6%) |
Mar 2019 | - | $5.55 M(+70.0%) |
Dec 2018 | $3.27 M(-89.0%) | $3.27 M(-10.4%) |
Sept 2018 | - | $3.65 M(-96.1%) |
June 2018 | - | $94.24 M(+1.2%) |
Mar 2018 | - | $93.17 M(+213.5%) |
Dec 2017 | $29.72 M(+65.9%) | $29.72 M |
Dec 2016 | $17.91 M | - |
FAQ
- What is Crinetics Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Crinetics Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Crinetics Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of CRNX is $52.30 M
What is the all time high annual total long term liabilities for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual total long term liabilities is $52.30 M
What is Crinetics Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, CRNX annual total long term liabilities has changed by +$44.18 M (+543.75%)
What is Crinetics Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of CRNX is $50.83 M
What is the all time high quarterly long term liabilities for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly total long term liabilities is $94.24 M
What is Crinetics Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, CRNX quarterly total long term liabilities has changed by -$2.49 M (-4.68%)